Shares of Ardent Health, Inc. (NYSE:ARDT – Get Free Report) fell 4.2% during trading on Wednesday . The stock traded as low as $9.42 and last traded at $9.3930. 85,825 shares were traded during mid-day trading, a decline of 78% from the average session volume of 394,473 shares. The stock had previously closed at $9.80.
Analyst Ratings Changes
Several brokerages have commented on ARDT. Leerink Partners decreased their price target on shares of Ardent Health from $16.00 to $15.00 and set an “outperform” rating for the company in a research report on Friday, March 6th. Royal Bank Of Canada decreased their price objective on shares of Ardent Health from $14.00 to $13.00 and set an “outperform” rating for the company in a research report on Monday, March 9th. Wall Street Zen raised shares of Ardent Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 16th. Zacks Research raised shares of Ardent Health from a “strong sell” rating to a “hold” rating in a research report on Wednesday, March 25th. Finally, UBS Group lifted their price objective on shares of Ardent Health from $13.00 to $13.50 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Seven analysts have rated the stock with a Buy rating, five have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $14.21.
View Our Latest Research Report on Ardent Health
Ardent Health Price Performance
Ardent Health (NYSE:ARDT – Get Free Report) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.28 EPS for the quarter, topping the consensus estimate of $0.18 by $0.10. The firm had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.58 billion. Ardent Health had a net margin of 2.09% and a return on equity of 13.85%. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. Research analysts anticipate that Ardent Health, Inc. will post 1.12 EPS for the current fiscal year.
Institutional Inflows and Outflows
A number of institutional investors have recently bought and sold shares of ARDT. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Ardent Health by 103.8% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,104 shares of the company’s stock valued at $194,000 after purchasing an additional 7,182 shares during the period. Goldman Sachs Group Inc. increased its stake in Ardent Health by 1,684.9% in the first quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock valued at $10,558,000 after purchasing an additional 724,841 shares during the period. Jane Street Group LLC increased its stake in Ardent Health by 235.1% in the first quarter. Jane Street Group LLC now owns 57,468 shares of the company’s stock valued at $790,000 after purchasing an additional 40,318 shares during the period. Acadian Asset Management LLC increased its stake in Ardent Health by 574.9% in the first quarter. Acadian Asset Management LLC now owns 40,238 shares of the company’s stock valued at $550,000 after purchasing an additional 34,276 shares during the period. Finally, Geode Capital Management LLC increased its stake in Ardent Health by 0.6% in the second quarter. Geode Capital Management LLC now owns 286,848 shares of the company’s stock valued at $3,918,000 after purchasing an additional 1,769 shares during the period.
Ardent Health Company Profile
Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.
Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.
Featured Stories
- Five stocks we like better than Ardent Health
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.
